← Every company
Structure Therapeutics Inc SEC Filings
What Structure Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
GPCR overview →Filings on file
49
since Jan 12, 2023
Warning signs
2
latest Nov 14, 2023
Last results
Aug 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 6, 2026 | Quarterly report 10-Q | Read ↗ |
| Aug 6, 2026 | Results announced 8-K | Read ↗ |
| Jun 18, 2026 | Shareholder vote 8-K | Read ↗ |
| May 7, 2026 | Quarterly report 10-Q | Read ↗ |
| May 7, 2026 | Results announcedMaterial agreement 8-K | Read ↗ |
| Apr 15, 2026 | Executive or director change 8-K | Read ↗ |
| Feb 26, 2026 | Annual report 10-K | Read ↗ |
| Feb 26, 2026 | Results announced 8-K | Read ↗ |
| Jan 5, 2026 | Material agreement 8-K | Read ↗ |
| Nov 6, 2025 | Quarterly report 10-Q | Read ↗ |
| Nov 6, 2025 | Results announced 8-K | Read ↗ |
| Aug 6, 2025 | Quarterly report 10-Q | Read ↗ |
| Aug 6, 2025 | Results announced 8-K | Read ↗ |
| Jun 25, 2025 | Shareholder vote 8-K | Read ↗ |
| May 8, 2025 | Quarterly report 10-Q | Read ↗ |
| May 8, 2025 | Results announced 8-K | Read ↗ |
| Feb 27, 2025 | Annual report 10-K | Read ↗ |
| Feb 27, 2025 | Results announced 8-K | Read ↗ |
| Nov 13, 2024 | Quarterly report 10-Q | Read ↗ |
| Nov 13, 2024 | Results announced 8-K | Read ↗ |
| Sep 17, 2024 | Executive or director change 8-K | Read ↗ |
| Aug 27, 2024 | Executive or director change 8-K | Read ↗ |
| Aug 8, 2024 | Quarterly report 10-Q | Read ↗ |
| Aug 8, 2024 | Results announced 8-K | Read ↗ |
| Jun 27, 2024 | Shareholder vote 8-K | Read ↗ |
| Jun 6, 2024 | Share offering 424B4 | Read ↗ |
| Jun 3, 2024 | Share offering S-1 | Read ↗ |
| May 9, 2024 | Quarterly report 10-Q | Read ↗ |
| May 9, 2024 | Results announced 8-K | Read ↗ |
| Mar 8, 2024 | Annual report 10-K | Read ↗ |
| Mar 8, 2024 | Results announced 8-K | Read ↗ |
| Nov 17, 2023 | Share offering S-1 | Read ↗ |
| Nov 17, 2023 | Quarterly report 10-Q | Read ↗ |
| Nov 17, 2023 | Quarterly report 10-Q/A | Read ↗ |
| Nov 16, 2023 | Quarterly report 10-Q/A | Read ↗ |
| Nov 14, 2023 | Late filing notice NT 10-Q | Read ↗ |
| Nov 14, 2023 | Results announcedMaterial agreement 8-K | Read ↗ |
| Sep 29, 2023 | Material agreementUnregistered share sale 8-K | Read ↗ |
| Aug 10, 2023 | Quarterly report 10-Q | Read ↗ |
| Aug 10, 2023 | Results announced 8-K | Read ↗ |
| Aug 4, 2023 | Executive or director change 8-K | Read ↗ |
| Jul 6, 2023 | Material agreement 8-K | Read ↗ |
| Jun 5, 2023 | Auditor change 8-K | Read ↗ |
| May 11, 2023 | Quarterly report 10-Q | Read ↗ |
| May 11, 2023 | Results announced 8-K | Read ↗ |
| Mar 30, 2023 | Annual report 10-K | Read ↗ |
| Mar 30, 2023 | Results announced 8-K | Read ↗ |
| Feb 6, 2023 | Share offering 424B4 | Read ↗ |
| Jan 12, 2023 | Share offering S-1 | Read ↗ |
Source: Structure Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on GPCR
Company overviewEverything on GPCR in one place, with the price.Insider tradingWhat GPCR's own officers and directors buy and sell.Planned salesSales GPCR insiders have filed notice of.Executive payWhat GPCR awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in GPCR.Funds holding itWhich funds and ETFs hold GPCR, and how big a bet.